Lumretuzumab (Anti-ERBB3 / HER3) | EGFR antibody | Read Reviews & Product Use Citations

Lumretuzumab (Anti-ERBB3 / HER3) is an immunoconjugate containing a glycoengineered, humanized monoclonal antibody directed against the human epidermal growth factor receptor HER3 (ErbB3) with potential antineoplastic activity. MW: 147.16 KD.

Purity & Quality Control

Batch: A290201 Purity: 99% Protein concentration: 4.45mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective EGFR Inhibitors

Biological Activity

Description	Lumretuzumab (Anti-ERBB3 / HER3) is an immunoconjugate containing a glycoengineered, humanized monoclonal antibody directed against the human epidermal growth factor receptor HER3 (ErbB3) with potential antineoplastic activity. MW: 147.16 KD.

References
[1] Schneeweiss A, et al. Invest New Drugs. 2018;36(5):848-859.

References

[1] Schneeweiss A, et al. Invest New Drugs. 2018;36(5):848-859.

Product Details

CAS No.	1448327-63-6
Molecular Weight	147.16
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field